Transcytos

Q: What is Transcytos's official website?

Transcytos's official website is www.transcytos.com

Q: What is Transcytos's Revenue?

Transcytos's revenue is <$5 Million

Q: What industry does Transcytos belong to?

Transcytos is in the industry of: Manufacturing , Pharmaceuticals , Business Services

Q: What technology does Transcytos use?

Some of the popular technologies that Transcytos uses are: Sentry, Sectigo, Wix, Liquidweb

Q: How do I contact Transcytos?

Transcytos contact info: Phone number: (203) 313-9400 Website: www.transcytos.com

Q: What does Transcytos do?

TransCytos is a medical instrumentation company focused on transforming cell and gene therapy to provide targeted, safe, personalized, and affordable cures for cancer and rare diseases. Utilizing their innovative non-viral Slipstream technology, they convert human T cells into CAR T cells, enabling effective treatment options for conditions like si... ckle cell anemia, lupus, and various cancers. Their commercialization strategy aims to deliver these therapies directly to patients at local hospitals, significantly reducing costs and improving accessibility. By partnering with pharmaceutical companies, TransCytos seeks to enhance treatment options and profitability while ensuring patients receive comprehensive and safer cures. Read More

Q: Is Transcytos a public company?

Transcytos is private company therefore does not currently have an official ticker symbol

Manufacturing · Massachusetts, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

56 Maggie Ln, Southbridge, Massachusetts...

Phone Number

(203) 313-9400

Website

www.transcytos.com

Revenue

<$5 Million

Industry

Manufacturing

Pharmaceuticals

Business Services

Research & Development

Medical Devices & Equipment

ZI Rank: 1

Signal Type

Mar

Apr

May

Jun

Jul

Aug

ZI Rank

About Transcytos

TransCytos is a medical instrumentation company focused on transforming cell and gene therapy to provide targeted, safe, personalized, and affordable cures for cancer and rare diseases. Utilizing their innovative non-viral Slipstream technology, they convert human T cells into CAR T cells, enabling effective treatment options for conditions like sickle cell anemia, lupus, and various cancers. Their commercialization strategy aims to deliver these therapies directly to patients at local hospitals, significantly reducing costs and improving accessibility. By partnering with pharmaceutical companies, TransCytos seeks to enhance treatment options and profitability while ensuring patients receive comprehensive and safer cures.Explore more

Is this data correct?

Popular SearchesTransCytosTransCytos LLCSIC Code 28,283NAICS Code 32,325Show more

Transcytos Org Chart

Otto Prohaska

Chief Executive Officer & Founder

Phone

Is Transcytos your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Website visits: Recent activity has been detected on your website

Transcytos, which may be a good buyer, showed buying intent in Masked Content Topic

Earning: See what the market has to say on Transcytos recently announced quarterly report

Check out if Transcytos is spiking on competitors!

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Click to see if Transcytos had a recent Job posting/layoffs

Congratulate Masked Content for being promoted to Masked Content at Transcytos

Check if Transcytos has recently received funding, and reach out quickly before it becomes old news!

Product Launch: Get notified when Transcytos launches new products

Funding: Get notified immidiatlly once Transcytos has new funding data

Recommended Actions

Find VP level buyers at Transcytos

Find 2 more new buyers

View Email Formats for Transcytos

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Transcytos is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Transcytos is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Transcytos.